{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:36:23Z","timestamp":1791405383766,"version":"4.3.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cholecystitis can represent a comorbidity during gallbladder cancer surgery; nonetheless, the prognostic impact of acute cholecystitis comorbidity remains unclear. This study aimed to evaluate the impact of acute cholecystitis comorbidity on prognosis after gallbladder cancer surgery, with adjustment for background factors using propensity score analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 218 patients who underwent gallbladder cancer surgery at our institute between 1986 and 2022 were retrospectively included in the analysis. Patients were divided into two groups according to the presence or absence of acute cholecystitis at the time of surgery. Background factors were adjusted by including intraoperative bile leakage as a covariate in propensity score calculation. Overall survival and recurrence-free survival were compared between the two groups using one-to-one propensity score matching and inverse probability weighting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 218 patients, 37 had coexisting acute cholecystitis. In one-to-one propensity score matching, the overall survival time in the acute cholecystitis group tended to be shorter than that in the non-acute cholecystitis group, although not significantly (hazard ratio, 2.41; 95% confidence interval, 0.96\u20136.06). Other analyses using inverse probability weighting showed significantly poor overall survival in the acute cholecystitis group. Regarding recurrence-free survival in propensity score matching, the acute cholecystitis group showed a significantly shorter duration than the non-acute cholecystitis group (hazard ratio, 6.69; 95% confidence interval, 1.46\u201330.6). The inverse probability weighting-adjusted analysis also indicated a significantly higher risk of recurrence in the acute cholecystitis group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Acute cholecystitis comorbidity at the time of gallbladder cancer surgery may have a negative impact on gallbladder cancer prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-023-03001-0","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T21:02:29Z","timestamp":1679950949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of acute cholecystitis comorbidity on prognosis after surgery for gallbladder cancer: a propensity score analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Yasuhiro","family":"Kihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yokomizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Murotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"3001_CR1","first-page":"99","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99\u2013109.","journal-title":"Clin Epidemiol"},{"key":"3001_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","volume":"98","author":"A Duffy","year":"2008","unstructured":"Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485\u20139.","journal-title":"J Surg Oncol"},{"key":"3001_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/jso.20537","volume":"93","author":"MC Misra","year":"2006","unstructured":"Misra MC, Guleria S. Management of cancer gallbladder found as a surprise on a resected gallbladder specimen. J Surg Oncol. 2006;93:690\u20138.","journal-title":"J Surg Oncol"},{"key":"3001_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00534-006-1152-y","volume":"14","author":"Y Kimura","year":"2007","unstructured":"Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, et al. Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo guidelines. J Hepato-Biliary-Pancreat Surg. 2007;14:15\u201326.","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"key":"3001_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/SLA.0000000000003325","volume":"273","author":"MJ Horkoff","year":"2021","unstructured":"Horkoff MJ, Ahmed Z, Xu Y, Sutherland FR, Dixon E, Ball CG, et al. Adverse outcomes after bile spillage in incidental gallbladder cancers: a population-based study. Ann Surg. 2021;273:139\u201344.","journal-title":"Ann Surg"},{"key":"3001_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.hbpd.2018.02.001","volume":"17","author":"N Goussous","year":"2018","unstructured":"Goussous N, Maqsood H, Patel K, Ferdosi H, Muhammad N, Sill AM, et al. Clues to predict incidental gallbladder cancer. Hepatobiliary Pancreat Dis Int. 2018;17:149\u201354.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"3001_CR7","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.jviscsurg.2011.02.005","volume":"148","author":"M Isambert","year":"2011","unstructured":"Isambert M, Leux C, M\u00e9tairie S, Paineau J. Incidentally-discovered gallbladder cancer: when, why and which reoperation? J Visc Surg. 2011;148:e77\u201384.","journal-title":"J Visc Surg"},{"key":"3001_CR8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jso.25617","volume":"120","author":"AM Blakely","year":"2019","unstructured":"Blakely AM, Wong P, Chu P, Warner SG, Raoof M, Singh G, et al. Intraoperative bile spillage is associated with worse survival in gallbladder adenocarcinoma. J Surg Oncol. 2019;120:603\u201310.","journal-title":"J Surg Oncol"},{"key":"3001_CR9","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1007\/s11605-012-1915-5","volume":"16","author":"G Clemente","year":"2012","unstructured":"Clemente G, Nuzzo G, Rose AMD, Giovannini I, Torre GL, Ardito F, et al. Unexpected gallbladder cancer after laparoscopic cholecystectomy for acute cholecystitis: a worrisome picture. J Gastrointest Surg. 2012;16:1462\u20138.","journal-title":"J Gastrointest Surg"},{"key":"3001_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4240\/wjgs.v8.i8.541","volume":"27","author":"G Clemente","year":"2016","unstructured":"Clemente G. Unexpected gallbladder cancer: surgical strategies and prognostic factors. World J Gastrointest Surg. 2016;27:541\u20134.","journal-title":"World J Gastrointest Surg"},{"key":"3001_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883\u201399.","journal-title":"Cell."},{"key":"3001_CR12","volume-title":"UICC TNM classification of malignant tumours, 8th ed","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C, editors. UICC TNM classification of malignant tumours, 8th ed. Wiley Blackwell: New York, NY; 2017."},{"key":"3001_CR13","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1245\/s10434-006-9219-1","volume":"14","author":"H Yokomizo","year":"2007","unstructured":"Yokomizo H, Yamane T, Hirata T, Hifumi M, Kawaguchi T, Fukuda S. Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome. Ann Surg Oncol. 2007;14:1366\u201373.","journal-title":"Ann Surg Oncol"},{"key":"3001_CR14","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1053\/j.gastro.2004.09.012","volume":"127","author":"K Kiyosawa","year":"2004","unstructured":"Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, et al. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology. 2004;127:S17\u201326.","journal-title":"Gastroenterology."},{"key":"3001_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.7326\/0003-4819-146-9-200705010-00008","volume":"146","author":"K Ikeda","year":"2007","unstructured":"Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, et al. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med. 2007;146:649\u201356.","journal-title":"Ann Intern Med"},{"key":"3001_CR16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJMoa001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784\u20139.","journal-title":"N Engl J Med"},{"key":"3001_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-005-1743-4","volume":"41","author":"T Chiba","year":"2006","unstructured":"Chiba T, Seno H, Marusawa H, Wakatsuki Y, Okazaki K. Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol. 2006;41:1\u20139.","journal-title":"J Gastroenterol"},{"key":"3001_CR18","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1200\/JCO.2010.27.9992","volume":"28","author":"C Ferrone","year":"2010","unstructured":"Ferrone C, Dranoff G. Dual roles for immunity in gastrointestinal cancers. J Clin Oncol. 2010;28:4045\u201351.","journal-title":"J Clin Oncol"},{"key":"3001_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028662","volume":"10","author":"MR Galdiero","year":"2018","unstructured":"Galdiero MR, Marone G, Mantovani A. Cancer inflammation and cytokines. Cold Spring Harb Perspect Biol. 2018;10:a028662.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3001_CR20","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1172\/JCI31537","volume":"117","author":"WW Lin","year":"2007","unstructured":"Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117:1175\u201383.","journal-title":"J Clin Invest"},{"key":"3001_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17:559\u201372.","journal-title":"Nat Rev Immunol"},{"key":"3001_CR22","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.hpb.2016.08.006","volume":"18","author":"EW Beal","year":"2016","unstructured":"Beal EW, Wei L, Ethun CG, Black SM, Dillhoff M, Salem A, et al. Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium. HPB (Oxford). 2016;18:950\u20137.","journal-title":"HPB (Oxford)"},{"key":"3001_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20:663\u201373.","journal-title":"Lancet Oncol"},{"key":"3001_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/jjco\/hyy004","volume":"48","author":"K Nakachi","year":"2018","unstructured":"Nakachi K, Konishi M, Ikeda M, Mizusawa J, Eba J, Okusaka T, et al. A randomized phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT). Jpn J Clin Oncol. 2018;48:392\u20135.","journal-title":"Jpn J Clin Oncol"},{"key":"3001_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1200\/JCO.2022.40.4_suppl.382","volume":"40","author":"M Ikeda","year":"2022","unstructured":"Ikeda M, Nakachi K, Konishi M, Nomura S, Katayama H, Kataoka T, et al. Adjuvant S-1 versus observation in curatively resected biliary tract cancer: a phase III trial (JCOG1202: ASCOT). J Clin Oncol. 2022;40:382.","journal-title":"J Clin Oncol"},{"key":"3001_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/ijc.23159","volume":"122","author":"K Yagyu","year":"2008","unstructured":"Yagyu K, Kikuchi S, Obata Y, Lin Y, Ishibashi T, Kurosawa M, et al. Cigarette smoking, alcohol drinking and the risk of gallbladder cancer death: a prospective cohort study in Japan. Int J Cancer. 2008;122:924\u20139.","journal-title":"Int J Cancer"},{"key":"3001_CR27","first-page":"271","volume":"31","author":"A Urata","year":"2017","unstructured":"Urata A, Takamori H, Kamio T. A case of cholecystocolic fistula caused by obstructive cholecystitis due to advanced cancer of the gallbladder. JJBA. 2017;31:271\u20138.","journal-title":"JJBA."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03001-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-03001-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03001-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T14:09:47Z","timestamp":1702130987000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-03001-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3001"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-03001-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2187718\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"20 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles embodied in the Declaration of Helsinki (as revised in 2013) and was approved by the ethics board of the Japanese Red Cross Kumamoto Hospital (permission no. 515). The requirement for informed consent was waived owing to the retrospective nature of this study. We posted a summary of the trial on our website and asked eligible patients to inform us if they wished to be excluded from the study; none of the participants requested exclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}